Sumitomo Dainippon Pharma (Japan)
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Sumitomo Dainippon Pharma (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
43%
Total
Publications
1.9K
Total Open
Publications
831
Total
Citations
58K
Open Access
Percentage
43%
Total
Publications
1.9K
Total Open
Publications
831
Total
Citations
58K
Breakdown
Publisher Open
23%
Both
17%
Other Platform Open
4%
Closed
56%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
301
Hybrid 18%
138
No Guarantees 43%
328
Other Platform Open
Domain 72%
299
Other Internet 24%
100
Institution 9%
38
Preprint 5%
21
Public 2%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 296 |
DOI | Other Internet | 100 |
Europe PMC | Domain | 26 |
bioRxiv | Preprint | 12 |
Hokkaido University | Institution | 7 |
Figshare | Public | 7 |
Research Square | Preprint | 6 |
Washington University in St. Louis | Institution | 3 |
Office of Scientific and Technical Information | Institution | 3 |
Nagasaki University | Institution | 3 |